Fujifilm to Make Full Entry into Antibody Therapeutics Market.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Feb 21, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Fuji Photo Film announced on February 20 that it has invested a total of 998 million yen ($8.3 mil An Internet address domain name for a military agency. See Internet address. (networking) mil - The top-level domain for entities affiliated with US armed forces. ) in Perseus Proteomics pro·te·o·mics n. The analysis of the expression, localization, functions, and interactions of the proteins produced by the genes of an organism. , a Tokyo-based bio venture company specializing in antibody therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , through a private placement. Fujifilm holds a leading 22% stake in Perseus Proteomics. With this move, Fujifilm aims to make a full entry into the antibody therapeutics market. Specifically, the two companies plan to develop a diagnosis system using disease-related biomarkers and introduce it to the market in 2008. Further, the partners will focus on developing a medical material by combining Fujifilm's proprietary materials with a molecule imaging technique that enables bio molecules to be visualized. They will also discover drug candidate compounds by using more than 200,000 chemical compounds that Fujifilm has obtained using its longstanding expertise in photography technology development. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion